| Patents for C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865) |
|---|
| 01/26/2006 | WO2006010082A1 1,4-disubstituted naphtalenes as inhibitors of p38 map kinase |
| 01/26/2006 | WO2001085170A9 Peptide deformylase inhibitors |
| 01/26/2006 | US20060020039 E.g., 3-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)phenoxy)benzamidine; 7-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)-4-fluorophenoxy)1-aminoisoquinoline; and 3-(2-(4-[(2-aminosulfonyl)phenyl]phenylaminocarbonyl-4-chlorophenoxy)benzamidine; highly selective |
| 01/26/2006 | US20060019988 Compounds, compositions, and methods |
| 01/26/2006 | US20060019973 agricultural and horticultural fungal infections of plants; novel N-alkynyl-2-quinolin-(isoquinolin- and quinazolin-)oxyalkylamides; 2-(6-quinolinyloxy)-N-(4-methylpent-2-yn-4-yl) butyramide |
| 01/26/2006 | DE102004031850A1 Substituirte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituirte tetrahydroisoquinolines as MMP inhibitors, to processes for their preparation and their use as a medicament |
| 01/26/2006 | CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient |
| 01/25/2006 | EP1618087A2 Antibacterial agents |
| 01/19/2006 | WO2005030130A3 Isoquinoline potassium channel inhibitors |
| 01/19/2006 | US20060014954 Microporous structure of an organic metal complex |
| 01/19/2006 | US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus |
| 01/19/2006 | US20060014830 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS |
| 01/19/2006 | US20060014783 Sulfonylamino-acetic acid derivatives |
| 01/19/2006 | US20060014752 Heterocyclic anti-epileptogenic agents and methods of use thereof |
| 01/19/2006 | US20060014739 Androgen receptor modulators and method of treating disease using the same |
| 01/18/2006 | EP1615878A2 Compounds, compositions and methods |
| 01/18/2006 | CN1723194A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/18/2006 | CN1721408A 1-benzyl tetrahydro isoquinoline compound, its preparing process and use thereof |
| 01/17/2006 | CA2138930C Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations based on these compounds |
| 01/12/2006 | WO2006002764A1 4-trifluoromethoxyphenoxybenzol-4'-sulfonic acids, method for the production and use thereof in medicaments |
| 01/12/2006 | WO2006002763A2 Substituted tetrahydroisochinolines used in the form of mmp inhibitors, method for the production and use thereof in the form of drags |
| 01/12/2006 | US20060009449 Naphthaline derivatives as H3 inverse agonists |
| 01/12/2006 | US20060008673 Electroluminescent efficiency |
| 01/12/2006 | US20060008671 Electroluminescent efficiency |
| 01/12/2006 | CA2572874A1 Urea derivative |
| 01/12/2006 | CA2572126A1 4-trifluoromethoxyphenoxybenzol-4'-sulfonic acids, method for the production and use thereof in medicaments |
| 01/12/2006 | CA2572125A1 Substituted tetrahydroisochinolines used in the form of mmp inhibitors, method for the production and use thereof in the form of drags |
| 01/11/2006 | EP1613600A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds |
| 01/11/2006 | EP1366036B1 Compounds having activity as inhibitors of cytochrome p450rai |
| 01/10/2006 | US6984735 Reacting a dihalaromatic compound with sulfoxide |
| 01/10/2006 | US6984647 Antiinflammatory agents; analgesics; antiarthritic agents |
| 01/05/2006 | US20060004066 Method for treating ADAMTS-5-associated disease |
| 01/05/2006 | US20060004041 Compounds for treatment of neurodegenerative diseases |
| 01/05/2006 | DE102004028973A1 Substituierte Tetrahydro-2H-isochinolin-1-on-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted tetrahydro-2H-isoquinolin-1-one derivatives, to processes for their preparation and their use as a medicament |
| 01/05/2006 | CA2589565A1 Amido compounds and their use as pharmaceuticals |
| 01/04/2006 | EP1611106A1 Preparation of quinapril hydrochloride |
| 01/04/2006 | EP1611105A1 Isoquinoline-5-sulfonic acid amides as inhibitors of akt (protein kinase b) |
| 01/04/2006 | EP1611104A1 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists |
| 01/04/2006 | EP1611102A2 Using alkylmetal reagents for directed metalation of azaaromatics |
| 01/04/2006 | EP1611088A2 Hydroxamates as therapeutic agents |
| 01/04/2006 | EP1363873A4 Peptide deformylase inhibitors |
| 01/04/2006 | CN1717175A Quinolin-, isoquinolin-, and quinazolin-oxyalkylamides and their use as fungicides |
| 01/03/2006 | US6982263 Peptidyl carbamates; treatments for osteoporosis and autoimmune diseases |
| 12/29/2005 | WO2005123743A1 Extraction of alkaloids from opium |
| 12/29/2005 | WO2005123687A1 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments |
| 12/29/2005 | WO2005123089A2 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 12/29/2005 | US20050288304 Tetrahydronaphthylpiperazines as 5HT1B antagonists, inverse agonists and partial agonists |
| 12/29/2005 | US20050288271 Arylsulfonamides and uses related thereto |
| 12/29/2005 | DE19748040B4 Carbonsäurederivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate, die diese Verbindungen enthalten Carboxylic acid derivatives, processes for their preparation and pharmaceutical preparations containing these compounds |
| 12/29/2005 | CA2569758A1 Extraction of alkaloids from opium |
| 12/28/2005 | EP1608625A1 Acutumine and acutumine compounds, synthesis and use |
| 12/28/2005 | EP1265867B1 Malonic acid derivates, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
| 12/28/2005 | EP1031563B1 Sulfonyl derivatives |
| 12/27/2005 | CA2189271C Novel erythromycin derivatives, method for their preparation and their use as drugs |
| 12/22/2005 | WO2005121130A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 12/22/2005 | WO2005121094A1 Piperazine and piperidine derivatives as anti-hiv-agents |
| 12/22/2005 | WO2005121073A1 Inhibitors of histone deacetylase |
| 12/22/2005 | WO2005120494A1 1-`(3r)-amino-4-(2-fluoro-phenyl)-butyl !-pyrrolidine-(2r)-carboxilic acid-benzyl amine derivatives and related compounds as dipeptidyl-peptidase iv (dpp-iv) inhibitors for the treatment of type 2 diabetes mellitus |
| 12/22/2005 | WO2005053610A3 Diamine and iminodiacetic acid hydroxamic acid derivatives |
| 12/22/2005 | US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/22/2005 | US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents |
| 12/22/2005 | CA2576236A1 1-`(3r)-amino-4-(2-fluoro-phenyl)-butyl !-pyrrolidine-(2r)-carboxilic acid-benzyl amine derivatives and related compounds as dipeptidyl-peptidase iv (dpp-iv) inhibitors for the treatment of type 2 diabetes mellitus |
| 12/22/2005 | CA2569111A1 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 12/22/2005 | CA2564499A1 Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity |
| 12/21/2005 | EP1606278A1 Substituted cyclohexyl and piperidinyl derivates as melanocortin-4 receptor modulators |
| 12/21/2005 | EP1605896A2 7-amino- isoindolyl compounds amd their pharmaceutical uses |
| 12/20/2005 | US6977266 Pyridone derivatives having affinity for cannabinoid 2-type receptor |
| 12/20/2005 | CA2302412C Aminoalkylphenol derivatives and related compounds |
| 12/15/2005 | WO2005118581A1 Tetrahydro-imidazo [1,5-a] pyridin derivatives as aldosterone synthase inhibitors |
| 12/15/2005 | WO2005118548A1 Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |
| 12/15/2005 | WO2005118547A1 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics |
| 12/15/2005 | WO2005118540A2 Bicyclic, nitrogen-containing heterocycles as aromatase inhibitors |
| 12/15/2005 | WO2005118538A2 Arylsulfonamides and uses as hydroxysteroid dehydrogenase |
| 12/15/2005 | WO2005117907A2 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions |
| 12/15/2005 | WO2005117876A1 Dual small molecule inhibitors of cancer and angiogenesis |
| 12/15/2005 | WO2005117865A1 Naphthaline derivatives useful as histamine-3-receptor ligands |
| 12/15/2005 | US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function |
| 12/15/2005 | US20050277631 Vanilloid receptor ligands and their use in treatments |
| 12/15/2005 | CA2568622A1 Dual small molecule inhibitors of cancer and angiogenesis |
| 12/15/2005 | CA2568163A1 Bicyclic, nitrogen-containing heterocycles as aromatase inhibitors |
| 12/15/2005 | CA2568159A1 Tetrahydro-imidazo [1,5-a] pyridin derivatives as aldosterone synthase inhibitors |
| 12/15/2005 | CA2561858A1 Arylsulfonamides and uses related thereto |
| 12/14/2005 | EP1604983A1 Receptor antagonist |
| 12/14/2005 | EP1604662A1 1-[(3R)-Amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2R)-carboxylic acid benzyl amine derivatives and related compounds as dipeptidyl peptidase IV (DPP-IV) inhibitors for the treatment of type 2 diabetes mellitus |
| 12/14/2005 | EP1603923A1 Metal complexes |
| 12/14/2005 | EP1440052B1 Benzamide derivatives as antagonists of orexin receptors |
| 12/14/2005 | EP1224165B1 Novel compounds |
| 12/14/2005 | CN1231439C Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand |
| 12/14/2005 | CN1231433C Transfer hydrogenation process |
| 12/13/2005 | US6974876 Method for preparing intermediates useful in synthesis of retroviral protease inhibitors |
| 12/13/2005 | US6974822 Treating osteoarthritis or rheumatoid arthritis |
| 12/08/2005 | WO2005115972A1 Therapeutic compounds |
| 12/08/2005 | WO2005115392A2 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors |
| 12/08/2005 | WO2005115361A2 Androgen receptor modulators and method of treating disease using the same |
| 12/08/2005 | WO2002057256A9 Piperazinylcarbonylquinolines and -isoquinolines |
| 12/08/2005 | US20050272931 Vanilloid receptor ligands and their use in treatments |
| 12/08/2005 | US20050272823 improved selectivity and pharmacokinetic properties; 6-Fluoro-1-[(1 H-indazol-4-yl)amino]-4,4-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalene-2,5-diol; cyclization of imines |
| 12/08/2005 | US20050272777 Vanilloid receptor ligands and their use in treatments |
| 12/08/2005 | US20050272745 Novel piperidine and piperazine derivatives |
| 12/08/2005 | DE102004017662B3 New 1-amino-tetrahydronaphthalene derivatives, useful for treatment of e.g. inflammation, bind with high selectivity to glucocorticoid receptors |